<DOC>
	<DOCNO>NCT02458430</DOCNO>
	<brief_summary>Balance gait problem cause severe impairment people Parkinson 's disease In Parkinson 's disease patient investigator see loss acetylcholine brain . In previous study investigator show loss acetylcholine relate impaired balance gait function Parkinson 's disease . In study investigator take close look finding .</brief_summary>
	<brief_title>Cholinergic Mechanisms Gait Dysfunction Parkinson 's Disease</brief_title>
	<detailed_description>Balance gait problem cause severe impairment people Parkinson 's disease significantly affect quality life . Several change occur brain Parkinson 's disease patient . The hallmark change loss neurotransmitter ( `` chemical messenger '' brain cell ) call dopamine . To alleviate Parkinson 's disease symptom doctor prescribe dopamine replacement therapy , example Sinemet ( levodopa ) . Although effective symptom , typically sufficiently alleviate balance gait problem . This study focus change brain occur Parkinson 's disease may contribute balance gait problem . In particular look another neurotransmitter call acetylcholine . In Parkinson 's disease patient see loss acetylcholine brain . In previous study show loss acetylcholine relate impaired balance gait function Parkinson 's disease . In study take close look finding .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Cholinergic Agents</mesh_term>
	<criteria>1 . Age 50 ( M/F ) . 2 . PD diagnosis ( without mild cognitive impairment ; MCI ) follow UK Parkinson 's Disease Society Brain Bank Research Center ( UKPDSBRC ) clinical diagnostic criterion PD ( 47 ) , consistent typical nigrostriatal denervation pattern VMAT2 . Absence significant dementia confirm neuropsychological testing . Modified Hoehn Yahr stag 14 ( 48 , 49 ) . 3 . PSP diagnosis follow NINDSPSP clinical diagnostic criterion ( 50 , 51 ) . 4 . All PD subject require nigrostriatal dopaminergic denervation demonstrate [ 11C ] DTBZ PET imaging ( 52 , 53 ) . Subjects Parkinsonism absence PDtypical pattern recategorized . 1 . Presence significant dementia . 2 . Disorders may resemble PD PSP , dementia Lewy body , vascular dementia , normal pressure hydrocephalus , multiple system atrophy , corticobasal ganglionic degeneration , toxic cause parkinsonism . The use UKPDSBRC NINDSPSP clinical diagnostic criterion mitigate inclusion patient atypical parkinsonism . 3 . Subjects neuroleptic ( except low dose quetiapine 2550 mg/d ) , anticholinergic ( trihexyphenidyl , benztropine ) , cholinesterase inhibitor . Subjects prior exposure disallow medication may eligible interval &gt; 2 month medication . 4 . Evidence large vessel stroke clinically relevant area ( cerebral cortex , basal ganglion , thalamus ) mass lesion structural brain imaging ( MRI CT ) . 5 . Participants magnetic resonance imaging ( MRI ) contraindicate include , limited , pacemaker , presence metallic fragment near eye spinal cord , cochlear implant . 6 . Severe claustrophobia preclude MR PET image . 7 . Subjects limit previous participation research procedures involve ionize radiation . 8 . Pregnancy ( test within 48 hour PET session ) breastfeed 9 . History deep brain stimulation surgery .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>